Vol 80, No 3 (2022)
Letter to the Editor
Published online: 2022-01-26

open access

Page views 4954
Article views/downloads 546
Get Citation

Connect on Social Media

Connect on Social Media

Cardiac paraganglioma: A challenging diagnostic and treatment dilemma

Mariola Pęczkowska1, Sonia J Konsek-Komorowska2
Pubmed: 35114002
Kardiol Pol 2022;80(3):378-379.

Abstract

Not available

References

  1. Redzek A, Preveden A, Todic M, et al. Primary neuroendocrine tumor of the heart. Successful management of an extremely rare disease. Kardiol Pol. 2021 [Epub ahead of print].
  2. Tella SH, Jha A, Taïeb D, et al. Comprehensive review of evaluation and management of cardiac paragangliomas. Heart. 2020; 106(16): 1202–1210.
  3. Wang JG, Han J, Jiang T, et al. Cardiac paragangliomas. J Card Surg. 2015; 30(1): 55–60.
  4. Hoekstra AS, Devilee P, Bayley JP. Models of parent-of-origin tumorigenesis in hereditary paraganglioma. Semin Cell Dev Biol. 2015; 43: 117–124.
  5. Crona J, Lamarca A, Ghosal S, et al. Genotype-phenotype correlations in pheochromocytoma and paraganglioma: a systematic review and individual patient meta-analysis. Endocr Relat Cancer. 2019; 26(5): 539–550.



Polish Heart Journal (Kardiologia Polska)